Product Description
Latanoprost, is a medication used to treat increased pressure inside the eye. This includes ocular hypertension and open angle glaucoma. It is applied as eye drops to the eyes. Onset of effects is usually within four hours, and they last for up to a day.
Common side effects include blurry vision, redness of the eye, itchiness, and darkening of the iris. Latanoprost is in the prostaglandin analogue family of medication. It works by increasing the outflow of aqueous fluid from the eyes through the uveoscleral tract.
Superior Medicine Grade QualityOur Latanoprost API adheres to stringent medicine-grade standards, making it suitable for pharmaceutical research and production. The high 99% purity guarantees optimal performance in finished antiglaucoma eye drops and blends seamlessly with established manufacturing processes.
Wide Application in Antiglaucoma SolutionsLatanoprost is a leading choice for antiglaucoma medication due to its proven ability to reduce elevated intraocular pressure. Its effectiveness and stability ensure broad applications in both generic and branded pharmaceuticals targeting ocular conditions.
Reliable Shelf Life and Supply ChainWith a substantial shelf life of 5 years, Latanoprost API maintains its chemical stability during storage and transit. Sourced, exported, and supplied directly from India, our product meets international demand for bulk medicinal intermediates, ensuring an uninterrupted supply.
FAQ's of Latanoprost Api:
Q: How is Latanoprost API used in the pharmaceutical industry?
A: Latanoprost API serves as a key pharmaceutical intermediate, primarily used in the manufacturing of antiglaucoma medications. It is formulated into eye drops that help lower intraocular pressure in patients with glaucoma or ocular hypertension.
Q: What benefits does Latanoprost offer as an antiglaucoma agent?
A: Latanoprost is highly effective in reducing intraocular pressure, thus helping to prevent optic nerve damage. Its use leads to improved management of glaucoma and helps preserve patients' vision.
Q: When should Latanoprost-based medication be used?
A: Latanoprost-based medications are usually prescribed when a patient is diagnosed with open-angle glaucoma or elevated intraocular pressure that can lead to vision loss if untreated. A healthcare professional determines the appropriate timing and dosage.
Q: Where is your Latanoprost API manufactured and supplied from?
A: Our Latanoprost API is manufactured, exported, and supplied from India, adhering to stringent international pharmaceutical standards for quality and safety.
Q: What is the shelf life and purity of your Latanoprost API?
A: Our Latanoprost API has a shelf life of 5 years and boasts a purity of 99%, ensuring stability and effectiveness during its storage and upon formulation.
Q: How can pharmaceutical companies acquire Latanoprost API from your company?
A: Interested pharmaceutical manufacturers, exporters, and traders can contact us directly to discuss bulk purchase, supply agreements, and export processes tailored to international markets.
Q: What is the typical process for using Latanoprost API in medicine formulation?
A: The API is incorporated into ophthalmic solutions during the formulation stage, where it undergoes rigorous quality checks before being compounded into finished antiglaucoma medications ready for market distribution.